Exploring the substrate scope of ferulic acid decarboxylase (FDC1) from Saccharomyces cerevisiae

• Published in: Scientific reports Vol. 9; no. 1; p. 647
• Main Authors: Nagy, Emma Zsófia Aletta, Nagy, Csaba Levente, Filip, Alina, Nagy, Katalin, Gál, Emese, Tőtős, Róbert, Poppe, László, Paizs, Csaba, Bencze, László Csaba
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 24.01.2019; Nature Publishing Group
• Subjects: 119/118; 140/131; 631/92/603; 639/638/60; 639/638/77/603; 82/16; Acids; Acrylic acid; Biocatalysts; Cinnamic acid; Computer applications; Decarboxylation; E coli; Ferulic acid; Flavin mononucleotide; Humanities and Social Sciences; multidisciplinary; Phenothiazine; Saccharomyces cerevisiae; Science; Science (multidisciplinary); Site-directed mutagenesis; Substrate specificity; Substrates; Yeast
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-018-36977-x

Ferulic acid decarboxylase from Saccharomyces cerevisiae ( Sc FDC1) was described to possess a novel, prenylated flavin mononucleotide cofactor (prFMN) providing the first enzymatic 1,3-dipolar cycloaddition mechanism. The high tolerance of the enzyme towards several non-natural substrates, combined with its high quality, atomic resolution structure nominates FDC1 an ideal candidate as flexible biocatalyst for decarboxylation reactions leading to synthetically valuable styrenes. Herein the substrate scope of Sc FDC1 is explored on substituted cinnamic acids bearing different functional groups (–OCH 3 , –CF 3 or –Br) at all positions of the phenyl ring ( o −, m −, p −) , as well as on several biaryl and heteroaryl cinnamic acid analogues or derivatives with extended alkyl chain. It was found that E. coli whole cells expressing recombinant Sc FDC1 could transform a large variety of substrates with high conversion, including several bulky aryl and heteroaryl cinnamic acid analogues, that characterize Sc FDC1 as versatile and highly efficient biocatalyst. Computational studies revealed energetically favoured inactive binding positions and limited active site accessibility for bulky and non-linear substrates, such as 2-phenylthiazol-4-yl-, phenothiazine-2-yl- and 5-(4-bromophenyl)furan-2-yl) acrylic acids. In accordance with the computational predictions, site-directed mutagenesis of residue I330 provided variants with catalytic activity towards phenothiazine-2-yl acrylic acid and provides a basis for altering the substrate specificity of ScFDC1 by structure based rational design.